Home › Compare › KSMRF vs ORCC

KSMRF vs ORCC: Dividend Comparison 2026

KSMRF yields 80000.00% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KSMRF wins by $5.2077213163602945e+25M in total portfolio value
10 years
KSMRF
KSMRF
● Live price
80000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.2077213163602945e+25M
Annual income
$51,949,472,569,259,090,000,000,000,000,000.00
Full KSMRF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — KSMRF vs ORCC

📍 KSMRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKSMRFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KSMRF + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KSMRF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KSMRF
Annual income on $10K today (after 15% tax)
$6,800,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,157,051,683,870,220,000,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, KSMRF beats the other by $44,157,051,683,870,220,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KSMRF + ORCC for your $10,000?

KSMRF: 50%ORCC: 50%
100% ORCC50/50100% KSMRF
Portfolio after 10yr
$2.6038606581801473e+25M
Annual income
$25,974,736,284,629,546,000,000,000,000,000.00/yr
Blended yield
99.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

KSMRF
No analyst data
Altman Z
-8181.2
Piotroski
1/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KSMRF buys
0
ORCC buys
0
No recent congressional trades found for KSMRF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKSMRFORCC
Forward yield80000.00% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$5.2077213163602945e+25M$21.4K ✓
Annual income after 10y$51,949,472,569,259,090,000,000,000,000,000.00 ✓$1.04
Total dividends collected$5.206883835920424e+25M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: KSMRF vs ORCC ($10,000, DRIP)

YearKSMRF PortfolioKSMRF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$8,010,700$8,000,000.00$11,190$489.61+$8.00M → KSMRF
2$5,997,879,860$5,989,308,411.21$12,229$256.01+$5997.87M → KSMRF
3$4,197,442,177,404$4,191,024,445,953.32$13,216$130.74+$4197442.16M → KSMRF
4$2,745,581,773,359,261$2,741,090,510,229,439.00$14,207$66.02+$2745581773.35M → KSMRF
5$1,678,610,723,842,080,800$1,675,672,951,344,586,500.00$15,234$33.17+$1678610723842.07M → KSMRF
6$959,257,110,940,495,000,000$957,460,997,465,984,000,000.00$16,317$16.62+$959257110940495.00M → KSMRF
7$512,381,218,321,420,100,000,000$511,354,813,212,713,760,000,000.00$17,468$8.32+$512381218321420096.00M → KSMRF
8$255,816,465,068,545,120,000,000,000$255,268,217,164,941,240,000,000,000.00$18,695$4.16+$255816465068545114112.00M → KSMRF
9$119,383,733,031,653,200,000,000,000,000$119,110,009,414,029,840,000,000,000,000.00$20,006$2.08+$1.193837330316532e+23M → KSMRF
10$52,077,213,163,602,950,000,000,000,000,000$51,949,472,569,259,090,000,000,000,000,000.00$21,407$1.04+$5.2077213163602945e+25M → KSMRF

KSMRF vs ORCC: Complete Analysis 2026

KSMRF — Stock

Contagious Gaming Inc. develops and provides software solutions for gaming and lottery markets primarily in Canada. The company offers an integrated end-end platform, which manages various aspects of real-money gaming, including gaming engine, player management tools, game application interface, payment systems interface, data feed handler, affiliate management, presentation layer, and proprietary centralized eWallet. It also provides web-based and mobile content for lottery, and real-money and social gaming applications; and Goal Time, an in-play pari-mutuel sports betting platform. The company is headquartered in Vancouver, Canada.

Full KSMRF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this KSMRF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KSMRF vs SCHDKSMRF vs JEPIKSMRF vs OKSMRF vs KOKSMRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.